US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Propanc Biopharma, Inc.

0.1898

-0.0121-5.99%

Post-market: 0.1800-0.0098-5.16%19:57 EST

Volume:2.09M

Turnover:388.62K

Market Cap:2.86M

PE:-0.04

High:0.2000

Open:0.1900

Low:0.1629

Close:0.2019

52wk High:11.00

52wk Low:0.0002

Shares:15.09M

Float Shares:6.73M

Volume Ratio:0.23

T/O Rate:31.07%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-4.9510

EPS(LYR):-14.8490

ROE:-1236.83%

ROA:-427.27%

PB:0.20

PE(LYR):-0.01

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Propanc Biopharma files to sell 7M shares of common stock for holders

Propanc Biopharma files new provisional patent application with IP Australia

Propanc Biopharma Develops Synthetic Enzyme Therapy for Metastatic Cancer

Propanc Biopharma Advances PRP Candidate Toward Human Trials for Pancreatic Cancer

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PPCB"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PPCB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PPCB\",,,,,undefined,":{"symbol":"PPCB","market":"US","secType":"STK","nameCN":"Propanc Biopharma, Inc.","latestPrice":0.1898,"timestamp":1770411600000,"preClose":0.2019,"halted":0,"volume":2092399,"hourTrading":{"tag":"盘后","latestPrice":0.18,"preClose":0.1898,"latestTime":"19:57 EST","volume":166336,"amount":31558.623891,"timestamp":1770425875697,"change":-0.0098,"changeRate":-0.051633,"amplitude":0.092202},"delay":0,"changeRate":-0.05993065874195146,"floatShares":6733900,"shares":15091099,"eps":-4.951,"marketStatus":"Market Closed","change":-0.0121,"latestTime":"02-06 16:00:00 EST","open":0.19,"high":0.2,"low":0.1629,"amount":388621.09887807997,"amplitude":0.183754,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-4.951,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"listingDate":1743998400000,"exchange":"NASDAQ","adjPreClose":0.2019,"preHourTrading":{"tag":"盘前","latestPrice":0.1904,"preClose":0.2019,"latestTime":"09:27 EST","volume":87059,"amount":16366.787293500001,"timestamp":1770388070895,"change":-0.0115,"changeRate":-0.056959,"amplitude":0.073304},"postHourTrading":{"tag":"盘后","latestPrice":0.18,"preClose":0.1898,"latestTime":"19:57 EST","volume":166336,"amount":31558.623891,"timestamp":1770425875697,"change":-0.0098,"changeRate":-0.051633,"amplitude":0.092202},"volumeRatio":0.2300319294195098},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PPCB\",,,,,undefined,":{"symbol":"PPCB","floatShares":6733900,"roa":"-427.27%","roe":"-1236.83%","lyrEps":-14.848963,"volumeRatio":0.2300319294195098,"shares":15091099,"dividePrice":0,"high":0.2,"amplitude":0.183754,"preClose":0.2019,"low":0.1629,"week52Low":0.0002,"pbRate":"0.20","week52High":11,"institutionHeld":0,"latestPrice":0.1898,"eps":-4.951,"divideRate":0,"volume":2092399,"delay":0,"ttmEps":-4.951,"open":0.19,"prevYearClose":0.536601,"prevWeekClose":0.2278,"prevMonthClose":0.2278,"prevQuarterClose":0.5366,"fiveDayClose":0.2278,"twentyDayClose":0.4804,"sixtyDayClose":0.902},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PPCB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-01-29","symbol":"PPCB","defaultRemindTime":1738161000000,"type":"split","dateTimestamp":1738126800000,"forFactor":60000,"toFactor":1,"ratio":60000},{"market":"US","date":"2023-05-23","symbol":"PPCB","defaultRemindTime":1684848600000,"type":"split","dateTimestamp":1684814400000,"forFactor":1000,"toFactor":1,"ratio":1000},{"market":"US","date":"2020-11-19","symbol":"PPCB","defaultRemindTime":1605796200000,"type":"split","dateTimestamp":1605762000000,"forFactor":1000,"toFactor":1,"ratio":1000},{"market":"US","date":"2019-06-24","symbol":"PPCB","type":"split","dateTimestamp":1561348800000,"forFactor":500,"toFactor":1,"ratio":500}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PPCB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PPCB\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PPCB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PPCB","date":"2026-02-05","current":-0.038336,"percent":1,"low":-1.336323,"twenty":-0.444729,"median":-0.196046,"eighty":-0.109875,"high":-0.040257,"avg":-0.295209,"sd":0.229488,"marketCap":2552570},"quantilePoints":[{"date":"2025-04-04","current":-0.050633,"twenty":-0.050633,"median":-0.050633,"eighty":-0.050633,"marketCap":84546},{"date":"2025-04-07","current":-0.048332,"twenty":-0.050633,"median":-0.050633,"eighty":-0.049713,"marketCap":80703},{"date":"2025-08-22","current":-0.938461,"twenty":-0.969897,"median":-0.655598,"eighty":-0.050633,"marketCap":51812834},{"date":"2025-08-29","current":-0.721182,"twenty":-0.884372,"median":-0.710781,"eighty":-0.050633,"marketCap":39816759},{"date":"2025-09-05","current":-0.457673,"twenty":-0.820575,"median":-0.688821,"eighty":-0.213449,"marketCap":25268328},{"date":"2025-09-12","current":-0.457673,"twenty":-0.778969,"median":-0.631034,"eighty":-0.41283,"marketCap":25268328},{"date":"2025-09-19","current":-0.506214,"twenty":-0.755854,"median":-0.517772,"eighty":-0.439644,"marketCap":27948302},{"date":"2025-09-26","current":-0.418378,"twenty":-0.712861,"median":-0.510837,"eighty":-0.435021,"marketCap":23098825},{"date":"2025-10-03","current":-0.399917,"twenty":-0.699454,"median":-0.498124,"eighty":-0.407301,"marketCap":23564414},{"date":"2025-10-10","current":-0.408611,"twenty":-0.69067,"median":-0.457673,"eighty":-0.403395,"marketCap":24076684},{"date":"2025-10-17","current":-0.343407,"twenty":-0.669984,"median":-0.449583,"eighty":-0.385572,"marketCap":20234660},{"date":"2025-10-24","current":-0.321672,"twenty":-0.645772,"median":-0.432247,"eighty":-0.369488,"marketCap":18953985},{"date":"2025-10-31","current":-0.269509,"twenty":-0.610693,"median":-0.4245,"eighty":-0.343407,"marketCap":15880366},{"date":"2025-11-07","current":-0.241906,"twenty":-0.556142,"median":-0.418378,"eighty":-0.313847,"marketCap":14253909},{"date":"2025-11-14","current":-0.169965,"twenty":-0.518234,"median":-0.404264,"eighty":-0.269509,"marketCap":10014876},{"date":"2025-11-21","current":-0.174454,"twenty":-0.514536,"median":-0.397743,"eighty":-0.234995,"marketCap":11061584},{"date":"2025-11-28","current":-0.188344,"twenty":-0.512687,"median":-0.384703,"eighty":-0.189884,"marketCap":11942288},{"date":"2025-12-05","current":-0.173885,"twenty":-0.509912,"median":-0.372748,"eighty":-0.182127,"marketCap":11025501},{"date":"2025-12-12","current":-0.170028,"twenty":-0.504827,"median":-0.356448,"eighty":-0.174606,"marketCap":10780935},{"date":"2025-12-19","current":-0.151754,"twenty":-0.498818,"median":-0.343407,"eighty":-0.171335,"marketCap":9622255},{"date":"2025-12-26","current":-0.139108,"twenty":-0.496968,"median":-0.326019,"eighty":-0.170682,"marketCap":8820401},{"date":"2026-01-02","current":-0.113099,"twenty":-0.476627,"median":-0.315152,"eighty":-0.168873,"marketCap":7171266},{"date":"2026-01-09","current":-0.101254,"twenty":-0.460447,"median":-0.284723,"eighty":-0.163023,"marketCap":6420182},{"date":"2026-01-16","current":-0.074044,"twenty":-0.457673,"median":-0.262988,"eighty":-0.151375,"marketCap":4694858},{"date":"2026-01-23","current":-0.056065,"twenty":-0.453513,"median":-0.243754,"eighty":-0.138341,"marketCap":3554888},{"date":"2026-01-30","current":-0.058573,"twenty":-0.449352,"median":-0.223866,"eighty":-0.121547,"marketCap":3713923},{"date":"2026-02-05","current":-0.040257,"twenty":-0.444729,"median":-0.196046,"eighty":-0.109875,"marketCap":2552570}],"updateTime":1770439760288},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PPCB\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2608881517","title":"Propanc Biopharma files to sell 7M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2608881517","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608881517?lang=en_us&edition=fundamental","pubTime":"2026-02-03 06:35","pubTimestamp":1770071725,"startTime":"0","endTime":"0","summary":"17:32 EST Propanc Biopharma (PPCB) files to sell 7M shares of common stock for holders Published first on TheFly – the ultimate source for real-tim...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/propanc-biopharma-files-to-sell-7m-shares-of-common-stock-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/propanc-biopharma-files-to-sell-7m-shares-of-common-stock-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PPCB"],"gpt_icon":0},{"id":"2604116209","title":"Propanc Biopharma files new provisional patent application with IP Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2604116209","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604116209?lang=en_us&edition=fundamental","pubTime":"2026-01-20 21:56","pubTimestamp":1768917418,"startTime":"0","endTime":"0","summary":"Propanc Biopharma (PPCB) announced that a new provisional patent application has been filed for methods of producing trypinsogen and chymotrypsinog...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/propanc-biopharma-files-new-provisional-patent-application-with-ip-australia-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/propanc-biopharma-files-new-provisional-patent-application-with-ip-australia-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LU1169589451.USD","BK4585","LU1169590202.USD","LU2463526074.USD","LU1481599808.USD","BK4136","BK4139","LU1481600234.SGD","PPCB","IE00B3T34201.USD","IP","LU1487256676.USD"],"gpt_icon":0},{"id":"2604116191","title":"Propanc Biopharma Develops Synthetic Enzyme Therapy for Metastatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2604116191","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604116191?lang=en_us&edition=fundamental","pubTime":"2026-01-20 21:45","pubTimestamp":1768916713,"startTime":"0","endTime":"0","summary":"Propanc Biopharma Inc. announced the filing of a new provisional patent application for methods of producing trypsinogen and chymotrypsinogen, utilizing an optimized expression system to create a fully synthetic recombinant version of PRP, aimed at treating and preventing metastatic cancer from solid tumors. The company highlights that this synthetic approach could offer significant advantages, including longer shelf life without refrigeration and consistent quality without relying on animal sources. These developments are part of Propanc's ongoing efforts to expand its intellectual property portfolio and develop novel cancer therapies. The announcement pertains to the patent filing and does not specify the presentation of scientific research results at this time.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes o","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nNDLT7tkQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","SG9999014013.SGD","LU2210149790.SGD","BK4585","SG9999014039.USD","IE00BGHQF748.EUR","BK4112","IE00BKPKM429.USD","BK4139","PPCB","SG9999014005.SGD","LU2210150020.SGD","IE00B3QW5Z07.USD","SG9999014021.USD","LU0314104364.USD","NDAQ","LU2095319765.USD","BK4588"],"gpt_icon":0},{"id":"2603198330","title":"Propanc Biopharma Advances PRP Candidate Toward Human Trials for Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2603198330","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603198330?lang=en_us&edition=fundamental","pubTime":"2026-01-15 21:45","pubTimestamp":1768484708,"startTime":"0","endTime":"0","summary":"Propanc Biopharma Inc. announced an update on its pancreatic cancer research, highlighting progress with its pancreatic proenzyme formulation, PRP. The company has not yet presented clinical research results but is advancing plans to initiate Phase I/II human clinical trials in 2026. These upcoming studies will begin with dose-finding and move to proof-of-concept trials for pancreatic and other cancers. Propanc emphasizes the scientific rationale behind PRP while acknowledging significant challenges in demonstrating clinical benefit in pancreatic cancer. The company remains in early-stage development and has not reported product revenues to date.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Propanc Biopharma Inc. published the origin","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nNDL3WSSjw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","IE00B3QW5Z07.USD","LU2210149790.SGD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","SG9999014013.SGD","LU0314104364.USD","BK4588","NDAQ","LU2095319765.USD","IE00BKPKM429.USD","SG9999014021.USD","SG9999014005.SGD","BK4585","SG9999014039.USD","BK4139","LU2210150020.SGD","PPCB"],"gpt_icon":0}],"pageSize":4,"totalPage":11,"pageCount":1,"totalSize":43,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/PPCB\",params:#limit:6,delay:false,,,undefined,":[]}}